Cargando…
Identifying Clinically and Functionally Distinct Groups Among Healthy Controls and First Episode Psychosis Patients by Clustering on EEG Patterns
OBJECTIVE: The mismatch negativity (MMN) is considered as a promising biomarker that can inform future therapeutic studies. However, there is a large variability among patients with first episode psychosis (FEP). Also, most studies report a single electrode site and on comparing case–control group d...
Autores principales: | Qu, Xiaodong, Liukasemsarn, Saran, Tu, Jingxuan, Higgins, Amy, Hickey, Timothy J., Hall, Mei-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530247/ https://www.ncbi.nlm.nih.gov/pubmed/33061914 http://dx.doi.org/10.3389/fpsyt.2020.541659 |
Ejemplares similares
-
EEG Microstate Differences in Medicated vs. Medication-Naïve First-Episode Psychosis Patients
por: Mackintosh, Amatya J., et al.
Publicado: (2020) -
Neural Autoantibodies in Cerebrospinal Fluid and Serum in Clinical High Risk for Psychosis, First-Episode Psychosis, and Healthy Volunteers
por: Bien, Christian G., et al.
Publicado: (2021) -
Neuroactive Steroids and Cognitive Functions in First-Episode Psychosis Patients and Their Healthy Siblings
por: Knytl, Pavel, et al.
Publicado: (2019) -
Meaning in Life in Long-Term Recovery in First-Episode Psychosis: An Interpretative Phenomenological Analysis
por: O'Keeffe, Donal, et al.
Publicado: (2021) -
Is It Possible to Predict the Future in First-Episode Psychosis?
por: Suvisaari, Jaana, et al.
Publicado: (2018)